How PitchCentric finds, scores, and books the shows that move pipeline.
An AI pitch grounded in a show's real recent episodes.
Score any podcast in seconds.
Estimate your reply rate before you send.
Embed your Pod Score on a guest page.
Run discovery, scoring, and outreach from Claude, Cursor, and any MCP client, sending from your own inbox.
Land the shows your investors and customers already hear.
The system of record for executive earned media.
Manage every client from one white-label workspace.
Ship executive appearances on a cadence investors notice.
How booking services work, and what they should cost.
Run your own outreach with booking intelligence.
How agencies and software stack up on cost and control.
We run the outreach end to end on the same platform. Managed booking from $1,500 per month.
Search 850,000+ shows scored for bookability.
Shows actively looking for guests, by category.
The newest episodes across every show, by industry.
Recurring guests with appearances and topics.
Podcast landscapes by vertical.
Every show scored by Pod Score and Booking Probability.
Enriched company profiles with industry and funding stage.
Spokespersons and founders with topics and guest history.
The full catalog, filterable and exportable.
The shows most likely to book a guest this week.
Highest Booking Probability overall.
Extended cut with niche shows.
The full long tail by Booking Probability.
Country cuts of the catalog by Booking Probability.
Curated top-100 lists by topic.
Step-by-step playbooks for podcast outreach.
How Pod Score and Booking Probability are calculated.
Definitions for every term we use.
A ready-to-send guest one-sheet.
A media kit producers can scan in seconds.
Weekly, quarterly, and evergreen reports on the podcast economy.
The topics rising and falling across the catalog this week.
The 20 companies most talked about on podcasts this week.
How comms teams use podcasts as earned media.
How-to guides, frameworks, and analysis.
A profile of the host worth pitching this month.
Loading…
A privately held drug discovery & development company focused on a novel approach to enable nucleic acid-based medicines.
Impilo Therapeutics has been mentioned across 1 podcast.
